CN1132629C - 酪氨酸和聚合过敏素的组合物 - Google Patents
酪氨酸和聚合过敏素的组合物 Download PDFInfo
- Publication number
- CN1132629C CN1132629C CN96193592A CN96193592A CN1132629C CN 1132629 C CN1132629 C CN 1132629C CN 96193592 A CN96193592 A CN 96193592A CN 96193592 A CN96193592 A CN 96193592A CN 1132629 C CN1132629 C CN 1132629C
- Authority
- CN
- China
- Prior art keywords
- tyrosine
- anaphylactin
- solution
- allergen
- compositions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 title claims abstract description 23
- 239000000203 mixture Substances 0.000 title claims abstract description 21
- 239000013566 allergen Substances 0.000 title claims abstract description 14
- 125000001493 tyrosinyl group Chemical group [H]OC1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 title description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims abstract description 25
- 239000000243 solution Substances 0.000 claims abstract description 25
- 239000008194 pharmaceutical composition Substances 0.000 claims abstract description 5
- 239000007864 aqueous solution Substances 0.000 claims abstract description 3
- 238000000034 method Methods 0.000 claims description 9
- 239000002253 acid Substances 0.000 claims description 6
- 238000006386 neutralization reaction Methods 0.000 claims description 6
- 241000238740 Dermatophagoides pteronyssinus Species 0.000 claims description 5
- 238000006116 polymerization reaction Methods 0.000 claims description 5
- 238000000975 co-precipitation Methods 0.000 claims description 4
- 230000035479 physiological effects, processes and functions Effects 0.000 claims description 4
- 206010002198 Anaphylactic reaction Diseases 0.000 claims description 3
- 230000036783 anaphylactic response Effects 0.000 claims description 3
- 208000003455 anaphylaxis Diseases 0.000 claims description 3
- 238000000586 desensitisation Methods 0.000 claims description 3
- 239000011248 coating agent Substances 0.000 claims description 2
- 238000000576 coating method Methods 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- 239000003814 drug Substances 0.000 claims 1
- 230000003472 neutralizing effect Effects 0.000 abstract description 2
- 239000011260 aqueous acid Substances 0.000 abstract 1
- 229960004441 tyrosine Drugs 0.000 description 16
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 5
- 238000000502 dialysis Methods 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 239000011780 sodium chloride Substances 0.000 description 5
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 230000007935 neutral effect Effects 0.000 description 3
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 239000000376 reactant Substances 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 235000003932 Betula Nutrition 0.000 description 1
- 241000219429 Betula Species 0.000 description 1
- 235000000509 Chenopodium ambrosioides Nutrition 0.000 description 1
- 244000098897 Chenopodium botrys Species 0.000 description 1
- 235000005490 Chenopodium botrys Nutrition 0.000 description 1
- ZNZYKNKBJPZETN-WELNAUFTSA-N Dialdehyde 11678 Chemical compound N1C2=CC=CC=C2C2=C1[C@H](C[C@H](/C(=C/O)C(=O)OC)[C@@H](C=C)C=O)NCC2 ZNZYKNKBJPZETN-WELNAUFTSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 239000003431 cross linking reagent Substances 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000004508 fractional distillation Methods 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- 230000000774 hypoallergenic effect Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 239000007972 injectable composition Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 238000000247 postprecipitation Methods 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000007614 solvation Methods 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000002435 venom Substances 0.000 description 1
- 210000001048 venom Anatomy 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/35—Allergens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/35—Allergens
- A61K39/36—Allergens from pollen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pulmonology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9508785.4 | 1995-04-29 | ||
GBGB9508785.4A GB9508785D0 (en) | 1995-04-29 | 1995-04-29 | Novel compositions |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1183046A CN1183046A (zh) | 1998-05-27 |
CN1132629C true CN1132629C (zh) | 2003-12-31 |
Family
ID=10773769
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN96193592A Expired - Lifetime CN1132629C (zh) | 1995-04-29 | 1996-04-25 | 酪氨酸和聚合过敏素的组合物 |
Country Status (20)
Country | Link |
---|---|
EP (1) | EP0825874A1 (sk) |
JP (1) | JPH11504338A (sk) |
KR (1) | KR19990008120A (sk) |
CN (1) | CN1132629C (sk) |
AU (1) | AU705873B2 (sk) |
BG (1) | BG63990B1 (sk) |
BR (1) | BR9608123A (sk) |
CA (1) | CA2217388A1 (sk) |
CZ (1) | CZ288401B6 (sk) |
EA (1) | EA199700271A1 (sk) |
GB (1) | GB9508785D0 (sk) |
HK (1) | HK1010834A1 (sk) |
HU (1) | HUP9802237A3 (sk) |
NO (1) | NO974893L (sk) |
NZ (1) | NZ308080A (sk) |
PL (1) | PL183484B1 (sk) |
SK (1) | SK281877B6 (sk) |
TR (1) | TR199701265T1 (sk) |
WO (1) | WO1996034626A1 (sk) |
ZA (1) | ZA963340B (sk) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9706957D0 (en) * | 1997-04-05 | 1997-05-21 | Smithkline Beecham Plc | Formulation |
GB9820525D0 (en) | 1998-09-21 | 1998-11-11 | Allergy Therapeutics Ltd | Formulation |
GB0000891D0 (en) | 2000-01-14 | 2000-03-08 | Allergy Therapeutics Ltd | Formulation |
GB201106802D0 (en) * | 2011-04-21 | 2011-06-01 | Allergy Therapeutics Ltd | Process for preparing vaccine composition |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4070455A (en) * | 1974-02-16 | 1978-01-24 | Beecham Group Limited | Process for preparing injectable desensitizing compositions and products thereof in microparticle form |
EP0058021A2 (en) * | 1981-02-06 | 1982-08-18 | Beecham Group Plc | Pharmaceutical compositions |
EP0367306A2 (en) * | 1988-11-04 | 1990-05-09 | Corporacion Biologica Farmaceutica, Sa (C.B.F. , S.A.) | Procedure for polymerized allergenis production |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1377074A (en) * | 1971-07-13 | 1974-12-11 | Beecham Group Ltd | Process for preparing injectable compositions |
-
1995
- 1995-04-29 GB GBGB9508785.4A patent/GB9508785D0/en active Pending
-
1996
- 1996-04-25 CZ CZ19973429A patent/CZ288401B6/cs not_active IP Right Cessation
- 1996-04-25 PL PL96323104A patent/PL183484B1/pl unknown
- 1996-04-25 NZ NZ308080A patent/NZ308080A/xx not_active IP Right Cessation
- 1996-04-25 EA EA199700271A patent/EA199700271A1/ru unknown
- 1996-04-25 HU HU9802237A patent/HUP9802237A3/hu unknown
- 1996-04-25 WO PCT/EP1996/001733 patent/WO1996034626A1/en not_active Application Discontinuation
- 1996-04-25 TR TR97/01265T patent/TR199701265T1/xx unknown
- 1996-04-25 JP JP8532981A patent/JPH11504338A/ja active Pending
- 1996-04-25 SK SK1461-97A patent/SK281877B6/sk not_active IP Right Cessation
- 1996-04-25 CA CA002217388A patent/CA2217388A1/en not_active Abandoned
- 1996-04-25 EP EP96914124A patent/EP0825874A1/en not_active Withdrawn
- 1996-04-25 AU AU57616/96A patent/AU705873B2/en not_active Expired
- 1996-04-25 CN CN96193592A patent/CN1132629C/zh not_active Expired - Lifetime
- 1996-04-25 KR KR1019970707645A patent/KR19990008120A/ko not_active Application Discontinuation
- 1996-04-25 BR BR9608123A patent/BR9608123A/pt not_active Application Discontinuation
- 1996-04-26 ZA ZA963340A patent/ZA963340B/xx unknown
-
1997
- 1997-10-23 NO NO974893A patent/NO974893L/no not_active Application Discontinuation
- 1997-10-29 BG BG102004A patent/BG63990B1/bg unknown
-
1998
- 1998-11-20 HK HK98112143A patent/HK1010834A1/xx not_active IP Right Cessation
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4070455A (en) * | 1974-02-16 | 1978-01-24 | Beecham Group Limited | Process for preparing injectable desensitizing compositions and products thereof in microparticle form |
EP0058021A2 (en) * | 1981-02-06 | 1982-08-18 | Beecham Group Plc | Pharmaceutical compositions |
EP0367306A2 (en) * | 1988-11-04 | 1990-05-09 | Corporacion Biologica Farmaceutica, Sa (C.B.F. , S.A.) | Procedure for polymerized allergenis production |
Also Published As
Publication number | Publication date |
---|---|
SK146197A3 (en) | 1998-05-06 |
JPH11504338A (ja) | 1999-04-20 |
TR199701265T1 (xx) | 1998-02-21 |
GB9508785D0 (en) | 1995-06-21 |
EP0825874A1 (en) | 1998-03-04 |
EA199700271A1 (ru) | 1998-04-30 |
BG63990B1 (bg) | 2003-09-30 |
NO974893D0 (no) | 1997-10-23 |
BR9608123A (pt) | 1999-02-09 |
PL183484B1 (pl) | 2002-06-28 |
NO974893L (no) | 1997-10-23 |
NZ308080A (en) | 1999-05-28 |
AU705873B2 (en) | 1999-06-03 |
KR19990008120A (ko) | 1999-01-25 |
WO1996034626A1 (en) | 1996-11-07 |
CZ288401B6 (en) | 2001-06-13 |
PL323104A1 (en) | 1998-03-16 |
CZ342997A3 (cs) | 1998-03-18 |
AU5761696A (en) | 1996-11-21 |
ZA963340B (en) | 1997-03-27 |
HK1010834A1 (en) | 1999-07-02 |
SK281877B6 (sk) | 2001-08-06 |
BG102004A (en) | 1998-11-30 |
HUP9802237A3 (en) | 2000-06-28 |
CA2217388A1 (en) | 1996-11-07 |
HUP9802237A2 (hu) | 1999-02-01 |
CN1183046A (zh) | 1998-05-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2146938C (en) | Method of controlling structure stability of collagen fibers produced from solutions or dispersions treated with sodium hydroxide for infectious agent deactivation | |
EP0284789B1 (en) | A process for the preparation of collagen and obtained product | |
EP0784632B1 (de) | Verfahren zur gewinnung von hochreinem von willebrand-faktor | |
CA1199597A (fr) | Procede de preparation industrielle de materiaux collageniques a partir de tissus placentaires humains, materiaux collageniques humains obtenus, leurs application comme biomateriaux | |
DE602005004014T2 (de) | Verfahren zur solubilisierung von peptid-mischungen | |
LV12284B (en) | BIOACTICAL PRODUCTS DERIVED FROM CEREALS AND CONTAINING PHARMACEUTICAL AND COSMETIC COMPOSITIONS | |
EP2293776B1 (de) | Lagerstabiles, funktionell intaktes virus-inaktiviertes fibrinogen | |
CN1132629C (zh) | 酪氨酸和聚合过敏素的组合物 | |
EP0457370B1 (de) | Verfahren zur Pasteurisierung des Gewebeproteins PP4 | |
US4070455A (en) | Process for preparing injectable desensitizing compositions and products thereof in microparticle form | |
EP0621044A2 (en) | Collagen membranes | |
CN109762184B (zh) | 一种胶原蛋白水凝胶的制备方法 | |
JP3146251B2 (ja) | ペプチド組成物とその製造法 | |
JPH0773507B2 (ja) | 低分子量ペプチド組成物およびその製造方法 | |
CN1260720A (zh) | 用作纤维蛋白封闭剂的组合物 | |
US5681586A (en) | Enzyme-modified soy and soy/casein combination healing compositions | |
JP3153811B2 (ja) | ペプシン処理ゼラチン | |
JPS5822444B2 (ja) | ヘンセイアレルゲンオユウスルチロシンノ セイゾウホウ | |
MXPA97008336A (en) | Composition of tyrosine and allergen polymerize | |
Piot et al. | Preparation of decolorized peptides from slaughter-house blood | |
JPH04306236A (ja) | 保存安定性に優れた絹フィブロイン水溶液及びその製造法 | |
JPH06305983A (ja) | 薬剤徐放用製剤 | |
JPH01261332A (ja) | プレカリクレイン賦活物質の不活化のためのキモトリプシンの用途 | |
EP0396597A1 (de) | Verfahren zur herstellung eines therapeutisch aktiven, insbesondere zur wundheilung oder zur behandlung in der geriatrie verwendbaren wirkstoffes und ein einen solchen wirkstoff enthaltendes therapeutisches präparat | |
DE69935338T2 (de) | Verwendung von mit Pepsin behandelter Gelatine als Stabilisator für einspritzbare Stoffe enthaltend Proteinenspuren |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CX01 | Expiry of patent term |
Granted publication date: 20031231 |
|
EXPY | Termination of patent right or utility model |